Quarry LP’s Neuropace NPCE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.56K Buy
+161
New +$2.59K ﹤0.01% 1478
2026
Q1
– Sell
-790
Closed -$12.2K – 2003
2025
Q4
$12.2K Sell
790
-3,055
-79% -$40.9K ﹤0.01% 1295
2025
Q3
$39.6K Buy
3,845
+1,872
+95% +$17.7K 0.01% 973
2025
Q2
$22K Buy
+1,973
New +$24.7K ﹤0.01% 1151

Other funds holding NPCE

Quarry LP's NPCE Position: Q2 2026 in Review

Quarry LP opened a new position in Neuropace (NPCE) in Q2 2026: 161 shares worth $2.56K. The stake represents ﹤0.01% of the portfolio and ranks #1478 among its holdings. This is a return to the name: Quarry LP previously reported a position in NPCE as recently as Q4 2025.

Quarry LP first reported a position in NPCE in Q2 2025 and has held it in 4 quarters since. The position peaked at $39.6K in Q3 2025. 112 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.

  • Quarry LP held 161 shares of Neuropace worth $2.56K as of Q2 2026.
  • Neuropace was a new Quarry LP position in Q2 2026.
  • Neuropace made up ﹤0.01% of Quarry LP's portfolio in Q2 2026, its #1478 holding.
  • Quarry LP first reported a position in Neuropace in Q2 2025 and has held it in 4 quarters since.
  • Quarry LP's Neuropace position peaked at $39.6K in Q3 2025.
  • 112 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.

Based on Quarry LP's 13F filing for Q2 2026, filed 14 Aug 2026.